SciSparc
About:
SciSparc is a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments.
Website: https://investor.scisparc.com
Description:
SciSparc Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. Our focus is creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the company is currently engaged in the following drug development programs based on tetrahydrocannabinol (THC) and/or non-psychoactive cannabidiol (CBD): THX-110 for the treatment of Tourette syndrome and for the treatment of obstructive sleep apnea; THX-160 for the treatment of pain; and THX-210 for the treatment of autism spectrum disorder and epilepsy.
$24.5M
$1M to $10M
Giv'atayim, Tel Aviv, Israel
2014-01-01
info(AT)therapixbio.com
11-50
2023-10-11
Public
© 2025 bioDAO.ai